Prosecution Insights
Last updated: October 04, 2026
Application No. 18/700,069

PROCESS FOR THE PREPARATION OF LOW-COLOR ALKYL POLYGLYCOSIDES, INVOLVING NEUTRALIZATION OF THE REACTION MEDIUM AFTER REMOVAL OF THE SUGAR

Non-Final OA §DP
Filed
Apr 10, 2024
Priority
Oct 13, 2021 — FR 2110845 +1 more
Examiner
BERRY, LAYLA D
Art Unit
Tech Center
Assignee
Société D'Exploitation De Produits Pour Les Industries Chimiques Seppic
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
3m
Est. Remaining
75%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
961 granted / 1456 resolved
+6.0% vs TC avg
Moderate +9% lift
Without
With
+9.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
55 currently pending
Career history
1481
Total Applications
across all art units

Statute-Specific Performance

§101
3.9%
-36.1% vs TC avg
§103
34.1%
-5.9% vs TC avg
§102
19.6%
-20.4% vs TC avg
§112
25.1%
-14.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1456 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . CONTINUING DATA This application is a 371 of PCT/EP2022/078401 10/12/2022 FOREIGN APPLICATIONS FRANCE 2110845 10/13/2021 Claims 1-14 are pending. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-14 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-15 of copending Application No. 18/700,526 (reference application). Reference claims 2-3 recite the same limitations as current claims 2-3. Reference claim 4 differs from current claim 4 because the basic agent can be sodium carbonate or sodium hydrogen carbonate, while current claim 4 requires sodium carbonate. Reference claim 9 recites the same limitations as current claim 5. Reference claim 1 recites that the pre-neutralization step obtains a reaction medium for which 5% dispersion of the reaction medium in water has a pH of between 3.5 and 5.5, and the neutralization step rests in a pH of 5.5-7.5. Reference claim 5 recites that the pre-neutralization is carried out with NaOH or KOH. The combination of reference claims 1 and 5 includes the limitations of current claim 6. Reference claim 7 recites the same limitations as current claim 7. Reference claim 8 recites the same limitations as current claim 8. Reference claim 10 recites the same limitations as current claim 9. Reference claim 11 recites the same limitations as current claim 10. Reference claim 12 recites the same limitations as current claim 11. Reference claim 13 recites the same limitations as current claim 12. Reference claim 14 recites the same limitations as current claim 13. Reference claim 15 recites the same limitations as current claim 14. The reference claims anticipate the current claims. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 1-5 and 7-14 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-14 of copending Application No. 18/700,569 (reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because the reference application claims a method which differs from the current claim 1 because it requires neutralization before removing the reducing sugar, while the current claims require removing the reducing sugar and then neutralizing. See claim 1. Current claim 1 does not include the pre-neutralizing step. Reference claims 2-3 recite the same limitations as current claims 2-3. Reference claim 4 differs from current claim 4 because the basic agent can be sodium carbonate or sodium hydrogen carbonate, while current claim 4 requires sodium carbonate. Reference claim 8 recites that the aqueous solution of Ab comprises 10-40% of Ab, which encompasses the limitation of current claim 5. Reference claim 6 recites the same limitations as current claim 7. Reference claim 7 recites the same limitations as current claim 8. Reference claim 9 recites the same limitations as current claim 9. Reference claims 10-11 recite the same limitations as current claims 10-11. Reference claims 12-14 recite the same limitations as current claims 12-14. It would have been obvious to one of ordinary skill in the art at the time the application was filed to modify the reference application by reversing the order of steps b) and c). MPEP 2144 states that selection of any order of performing process steps is prima facie obvious in the absence of new or unexpected results. The examiner did not find evidence of unexpected results regarding the order of steps. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Conclusion No claims are allowed. Liu (JP S 47-24532, machine translation) is representative of the closest prior art. Liu teaches methods which differ from the claimed method because they do not include removal of reducing sugar, they include removal of R-OH which cause the amount of R-OH in the product to be negligible, and they do not result in a color of less than or equal to 1.5 VCS. Example 6 results in a product which contains reducing sugars and only 0.8 % of R-OH. The color is yellowish-brown, which corresponds to a color greater than 1.5 VCS (1.0 VCS corresponding to white, 1.5-2.0 VCS slightly yellowish, 3.0 to 5.0 yellow/amber, and above 5.0 deep yellow to brown). Liu does not suggest omitting the step of removing R-OH or how that step impacts color. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LAYLA D BERRY whose telephone number is (571)272-9572. The examiner can normally be reached 7:00-3:00 CST, M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LAYLA D BERRY/Primary Examiner, Art Unit 1693
Read full office action

Prosecution Timeline

Apr 10, 2024
Application Filed
Aug 11, 2026
Non-Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746249
A Method for Drying Human Milk Oligosaccharides
4y 4m to grant Granted Sep 29, 2026
Patent 12747242
PROCESS FOR THE CATALYTIC GLYCOSYLATION OF ARENES
2y 8m to grant Granted Sep 29, 2026
Patent 12746198
AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
3y 4m to grant Granted Sep 29, 2026
Patent 12741029
Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient
4y 9m to grant Granted Sep 22, 2026
Patent 12741985
A PROCESS FOR ISOLATION OF SAPONINS UTTROSIDE B AND UTTROSIDE A FROM SOLANUM NIGRUM LINN
3y 0m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
75%
With Interview (+9.0%)
2y 9m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1456 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month